Covid-19: Remdesivir has "small effect" against death or progression to ventilation, WHO trial finds. | BMJ;377: o1118, 2022 05 04. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Covid-19: Remdesivir has "small effect" against death or progression to ventilation, WHO trial finds.

Mahase, Elisabeth.

Mahase E; The BMJ.

BMJ ; 377: o1118, 2022 05 04.

Article in English | MEDLINE | ID: covidwho-1832411

Subject(s)

COVID-19 Drug Treatment; Adenosine Monophosphate/analogs & derivatives; Adenosine Monophosphate/therapeutic use; Alanine/analogs & derivatives; Antiviral Agents/therapeutic use; Humans; Treatment Outcome; World Health Organization

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: BMJ Journal subject: Medicine Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: BMJ Journal subject: Medicine Year: 2022 Document Type: Article